Transgenic Overexpression of Galectin-3 in Pancreatic β Cells Attenuates Hyperglycemia in Mice: Synergistic Antidiabetic Effect With Exogenous IL-33.

Results

Title:	Transgenic Overexpression of Galectin-3 in Pancreatic β Cells Attenuates Hyperglycemia in Mice: Synergistic Antidiabetic Effect With Exogenous IL-33.
Authors :	Srejović, Ivan
Issue Date:	2021
Publication:	Frontiers in Pharmacology
ISSN:	1663-9812 Frontiers in Pharmacology Search Idenfier
Publisher:	Lausanne: Frontiers Media S.A.
Type:	Article
Collation:	vol. 12 str. 714683
DOI:	10.3389/fphar.2021.714683
WoS-ID:	000722354200001
Scopus-ID:	2-s2.0-85119409943
PMID:	34803672
URI:	https://www.frontiersin.org/articles/10.3389/fphar.2021.714683/full http://radar.ibiss.bg.ac.rs/handle/123456789/4697 https://enauka.gov.rs/handle/123456789/336969 https://scidar.kg.ac.rs/handle/123456789/13986
URL:	https://www.frontiersin.org/articles/10.3389/fphar.2021.714683/full
Project:	Uticaj IL-33/ST2 signalnog puta i galektina-3 u patogenezi eksperimentalnih periapikalnih promena (RS-175071) Swiss National Science Foundation Faculty of Medical Sciences, University of Kragujevac, Serbia (JP13-17)
M-category:	21aM21a

7
SCOPUS^TM

4
PubMed Central^TM

1
OpenCitations

7
WEB OF SCIENCE^TM

Altmetric

Dimensions

Unpaywall

Creative Commons License